XML 144 R52.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Summary of Quarterly Data (Unaudited) (Tables)
12 Months Ended
Dec. 31, 2019
Quarterly Financial Data [Abstract]  
Schedule of Quarterly Data

A summary of quarterly data (1) follows:
(in thousands, except per share data)
 
For the Three Months Ended

 
March 31,
 
June 30,
 
September 30,
 
December 31,

 
 

 
 

 
 

 
 

2019
 
 

 
 

 
 

 
 

Revenue
 
$
576,056

 
$
620,103

 
$
605,303

 
$
605,446

Gross profit
 
$
331,597

 
$
357,853

 
$
344,950

 
$
331,149

Operating income
 
$
133,138

 
$
164,275

 
$
139,802

 
$
115,631

Net income attributable to IDEXX Laboratories, Inc. stockholders
 
$
102,681

 
$
125,706

 
$
108,837

 
$
90,496

Earnings per share:
 
 
 
 
 
 
 
 
Basic
 
$
1.19

 
$
1.46

 
$
1.26

 
$
1.05

Diluted
 
$
1.17

 
$
1.43

 
$
1.24

 
$
1.04


 
 
 
 
 
 
 
 
2018
 
 
 
 
 
 
 
 
Revenue
 
$
537,656

 
$
580,752

 
$
545,448

 
$
549,386

Gross profit
 
$
303,099

 
$
332,439

 
$
305,643

 
$
300,361

Operating income
 
$
113,044

 
$
145,594

 
$
117,350

 
$
115,347

Net income attributable to IDEXX Laboratories, Inc. stockholders
 
$
89,451

 
$
108,691

 
$
93,251

 
$
85,638

Earnings per share:
 
 
 
 
 
 
 
 
Basic
 
$
1.02

 
$
1.25

 
$
1.07

 
$
0.99

Diluted
 
$
1.01

 
$
1.23

 
$
1.05

 
$
0.98

(1)
Amounts presented may not recalculate to full-year totals due to rounding.